Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jun-Xiao Qiao"'
Autor:
Mei Guo, Wan-Jun Sun, Ya-Jing Huang, Zhenhua Qiao, Bao-fu Shi, Jian-Hui Qiao, Qi-Yun Sun, Hong-Li Zuo, Yingmin Liang, Xiao-Jun Huang, Hui-Sheng Ai, Bao-An Chen, Huang-He, Jianmin Wang, Zheng-Dong, Jun-Xiao Qiao, Chang-Lin Yu, Bai-Hai, Kai-Xun Hu, Depei Wu
Publikováno v:
Annals of Hematology. 96:279-288
This study compared 6-year follow-up data from patients undergoing reduced-intensity conditioning (RIC) transplantation with an HLA-matched related donor (MRD), an HLA-matched unrelated donor (MUD), or an HLA-haploidentical donor (HID) for leukemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c08cb02a20b47943edb5a0a5bac30f6
https://doi.org/10.1007/s00277-016-2864-y
https://doi.org/10.1007/s00277-016-2864-y
Autor:
Wan-Jun Sun, Jun-Xiao Qiao, Bo Cai, Ya-Jing Huang, Mei Guo, Chang-Lin Yu, Jian-Hui Qiao, Hong-Li Zuo, Hui-Sheng Ai, Kai-Xun Hu, Qi-Yun Sun, Zheng Dong
Publikováno v:
Stem Cells Translational Medicine. 5:524-529
The treatment outcomes of myelodysplastic syndrome (MDS) and transformed acute myelogenous leukemia (tAML) remain very unsatisfactory. We designed a combination of human leukocyte antigen (HLA)-mismatched hematopoietic stem cell microtransplantation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a7e91a4b0632feb659d62bfa162b160
https://doi.org/10.5966/sctm.2015-0196
https://doi.org/10.5966/sctm.2015-0196
Publikováno v:
Iranian Journal of Pharmaceutical Research. 2014, Vol. 13 Issue 4, p1213-1219. 7p.
Autor:
Kai-Xun Hu, Jian-Hui Qiao, Hui-Sheng Ai, Bo Cai, Hong-Li Zuo, Anthony D. Sung, Lin-Hua Yang, Xuliang Shen, Wei-Wei Liu, Yang-Yi Bao, Wan-Jun Sun, Elizabeth F. Krakow, Depei Wu, Rafael Fores, Qi-Yun Sun, Xinrong Zhan, Li Liu, Ann Mohrbacher, David A. Rizzieri, Jian-Yong Li, Si-Xuan Qian, Nelson J. Chao, Juan Wang, Zhiqing Liu, Ya-Jing Huang, Zheng Dong, Bo Yao, Hong-Xia Zhao, Tie-Qiang Liu, Jun-Xiao Qiao, Chang-Lin Yu, Rafael F. Duarte, Min Zhou, Mei Guo
Importance The outcome of older patients with acute myeloid leukemia (AML) remains unsatisfactory. Recent studies have shown that HLA-mismatched microtransplant could improve outcomes in such patients. Objective To evaluate outcomes in different age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e27d342a97ee759f71763cbcc847569
https://europepmc.org/articles/PMC5833633/
https://europepmc.org/articles/PMC5833633/
Autor:
Wan-Jun Sun, Zheng Dong, Guang-Xian Liu, Xue-Dong Sun, Ya-Jing Huang, Li Wei, Jian-Hui Qiao, Jun-Xiao Qiao, Kai-Xun Hu, Qi-Yun Sun, Chang-Lin Yu, Mei Guo, Hui-Sheng Ai, Dan-Hong Wang
Publikováno v:
Blood. 117:936-941
Treatment outcome of acute myeloid leukemia (AML) in elderly patients remains unsatisfactory. It has been shown that the infusion of granulocyte colony-stimulating factor–mobilized donor peripheral blood stem cells (G-PBSCs) can enhance graft-versu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5b7c710340aaba8332b124494a3192
https://doi.org/10.1182/blood-2010-06-288506
https://doi.org/10.1182/blood-2010-06-288506
Autor:
Hong-xia, Zhao, Wan-jun, Sun, Jie, Li, Jun-xiao, Qiao, Ya-jing, Huang, Hai-lan, Hu, Hui-sheng, Ai
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 34(11)
To evaluate the anti-leukemia effects of prophylactic G-CSF mobilized donor lymphocytes infusion (pG-DLI) and its relationship with the incidence of graft-versus-host disease (GVHD) in high-risk leukemia patients with non-myeloablative stem cell tran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::27ae5d08402508daf2aeac5b34c9d14c
https://pubmed.ncbi.nlm.nih.gov/24294845
https://pubmed.ncbi.nlm.nih.gov/24294845
Autor:
Tie-Qiang Liu, Jun-Xiao Qiao, Zhiqing Liu, Jian-Hui Qiao, Chang-Lin Yu, Bing Liu, Mei Guo, Juan Wang, Li Wei, Guang-xian Liu, Wan-Jun Sun, Qiu-Hong Man, Hong-Li Zuo, Xue-Dong Sun, Zheng Dong, Hong-Xia Zhao, Ya-Jing Huang, Kai-Xun Hu, Hui-Sheng Ai, Qi-Yun Sun, Xuliang Shen
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(33)
Purpose Despite best current therapies, approximately half of patients with acute myeloid leukemia in first complete remission (AML-CR1) with no HLA-identical donors experience relapse. Whether HLA-mismatched stem-cell microtransplantation as a novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0825ea2166d8e70f26cf4e11fa30e1ae
https://pubmed.ncbi.nlm.nih.gov/23045583
https://pubmed.ncbi.nlm.nih.gov/23045583
Autor:
Wan-Jun Sun, Xinrong Zhan, Liangping Hu, Bo Yao, Hong-Li Zuo, Qi-Yun Sun, Ya-Jing Huang, Tie-Qiang Liu, Jun-Xiao Qiao, Juan Wang, Zhiqing Liu, Chang-Lin Yu, Kai-Xun Hu, Hui-Sheng Ai, Bo Cai, Xuliang Shen, Jianyong Li, Mei Guo, Zheng Dong, Qianqian Zhou, Jian-Hui Qiao, Xue-Dong Sun, Hong-Xia Zhao
Publikováno v:
Blood. 126:156-156
The optimal therapy for intermediate-risk patients with acute myeloid leukemia (AML) in first complete remission (CR1) is uncertain. Recent studies shown that microtransplantation (MST) can improve survival in AML-CR1 patients. However, a comparison
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fa25d8f14114e07f198afdf69e396d4
https://doi.org/10.1182/blood.v126.23.156.156
https://doi.org/10.1182/blood.v126.23.156.156
Autor:
Mei Guo, Hong-Li Zuo, Qi-Yun Sun, Xuzhang Lu, Hui-Sheng Ai, Lin-Hua Yang, Hong-Xia Zhao, Jian-Hui Qiao, Jianyong Li, Bo Cai, Xinrong Zhan, Li Liu, Zheng Dong, Juan Wang, Tie-Qiang Liu, Jun-Xiao Qiao, Chang-Lin Yu, Ya-Jing Huang, Depei Wu, Yang-Yi Bao, Wan-Jun Sun, Kai-Xun Hu, Bo Yao, Xuliang Shen, Zhiqing Liu
Publikováno v:
Blood. 126:455-455
The acute myeloid leukemia in elderly patients (EAML) is always associated with low complete remission (CR) rate and a poor survival due to prolonged pancytopenia and resistance of leukemic blasts to chemotherapy. The standard or high dose induction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb0519acde6ec88565df3fb30274a77e
https://doi.org/10.1182/blood.v126.23.455.455
https://doi.org/10.1182/blood.v126.23.455.455
Autor:
Mei Guo, Guang-Xian Liu, Jun-Xiao Qiao, Jian-Hui Qiao, Qi-Yun Sun, Xiao Li, Hui-Sheng Ai, Zheng Dong, Chang-Lin Yu, Zhenhua Qiao, Kai-Xun Hu
Publikováno v:
Blood. 120:1709-1709
Abstract 1709 The outcome of myelodysplastic syndromes (MDS) still remains unsatisfactory, with a low complete remission (CR) rate and a poor overall survival rate. Decitabine improved the overall responses of MDS as a hypomethylating agent, but CR r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b252dcd13cfdfb48d046690a0412bfc5
https://doi.org/10.1182/blood.v120.21.1709.1709
https://doi.org/10.1182/blood.v120.21.1709.1709